HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight
Daniel I Swerdlow,
David Preiss,
Karoline B Kuchenbaecker,
Michael V Holmes,
Jorgen EL Engmann,
Tina Shah,
Reecha Sofat,
Stefan Stender,
Paul CD Johnson,
Robert A Scott,
Maarten Leusink,
Niek Verweij,
Stephen J Sharp,
Yiran Guo,
Claudia Giambartolomei,
Christina Chung,
Anne Peasey,
Antoinette Amuzu,
KaWah Li,
Jutta Palmen,
Philip Howard,
Jackie A Cooper,
Fotios Drenos,
Yun R Li,
Gordon Lowe,
John Gallacher,
Marlene CW Stewart,
Ioanna Tzoulaki,
Sarah G Buxbaum,
Daphne L van der A,
Nita G Forouhi,
N Charlotte Onland-Moret,
Yvonne T van der Schouw,
Renate B Schnabel,
Jaroslav A Hubacek,
Ruzena Kubinova,
Migle Baceviciene,
Abdonas Tamosiunas,
Andrzej Pajak,
Roman Topor-Madry,
Urszula Stepaniak,
Sofia Malyutina,
Damiano Baldassarre,
Bengt Sennblad,
Elena Tremoli,
Ulf de Faire,
Fabrizio Veglia,
Ian Ford,
J Wouter Jukema,
Rudi GJ Westendorp,
Gert Jan de Borst,
Pim A de Jong,
Ale Algra,
Wilko Spiering,
Anke H Maitland-van der Zee,
Olaf H Klungel,
Anthonius de Boer,
Pieter A Doevendans,
Charles B Eaton,
Jennifer G Robinson,
David Duggan,
DIAGRAM Consortium,
MAGIC Consortium,
InterAct Consortium,
John Kjekshus,
John R Downs,
Antonio M Gotto,
Anthony C Keech,
Roberto Marchioli,
Gianni Tognoni,
Peter S Sever,
Neil R Poulter,
David D Waters,
Terje R Pedersen,
Pierre Amarenco,
Haruo Nakamura,
John JV McMurray,
James D Lewsey,
Daniel I Chasman,
Paul M Ridker,
Aldo P Maggioni,
Luigi Tavazzi,
Kausik K Ray,
Sreenivasa Rao Kondapally Seshasai,
JoAnn E Manson,
Jackie F Price,
Peter H Whincup,
Richard W Morris,
Debbie A Lawlor,
George Davey Smith,
Yoav Ben-Shlomo,
Pamela J Schreiner,
Myriam Fornage,
David S Siscovick,
Mary Cushman,
Meena Kumari,
Nick J Wareham,
WM Monique Verschuren,
Susan Redline,
Sanjay R Patel,
John C Whittaker,
Anders Hamsten,
Joseph A Delaney,
Caroline Dale,
Tom R Gaunt,
Andrew Wong,
Diana Kuh,
Rebecca Hardy,
Sekar Kathiresan,
Berta A Castillo,
Pim van der Harst,
Eric J Brunner,
Anne Tybjaerg-Hansen,
Michael G Marmot,
Ronald M Krauss,
Michael Tsai,
Josef Coresh,
Ronald C Hoogeveen,
Bruce M Psaty,
Leslie A Lange,
Hakon Hakonarson,
Frank Dudbridge,
Steve E Humphries,
Philippa J Talmud,
Mika Kivimäki,
Nicholas J Timpson,
Claudia Langenberg,
Folkert W Asselbergs,
Mikhail Voevoda,
Martin Bobak,
Hynek Pikhart,
James G Wilson,
Alex P Reiner,
Brendan J Keating,
Aroon D Hingorani,
Naveed Sattar
Nov 07, 2018
BACKGROUND: Statins increase the risk of new-onset type 2 diabetes mellitus. We aimed to assess whether this increase in risk is a consequence of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the intended drug...